Cargando…
A 16-Gene Signature Distinguishes Anaplastic Astrocytoma from Glioblastoma
Anaplastic astrocytoma (AA; Grade III) and glioblastoma (GBM; Grade IV) are diffusely infiltrating tumors and are called malignant astrocytomas. The treatment regimen and prognosis are distinctly different between anaplastic astrocytoma and glioblastoma patients. Although histopathology based curren...
Autores principales: | Rao, Soumya Alige Mahabala, Srinivasan, Sujaya, Patric, Irene Rosita Pia, Hegde, Alangar Sathyaranjandas, Chandramouli, Bangalore Ashwathnarayanara, Arimappamagan, Arivazhagan, Santosh, Vani, Kondaiah, Paturu, Rao, Manchanahalli R. Sathyanarayana, Somasundaram, Kumaravel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901657/ https://www.ncbi.nlm.nih.gov/pubmed/24475040 http://dx.doi.org/10.1371/journal.pone.0085200 |
Ejemplares similares
-
miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma
por: Rao, Soumya Alige Mahabala, et al.
Publicado: (2013) -
A Fourteen Gene GBM Prognostic Signature Identifies Association of Immune Response Pathway and Mesenchymal Subtype with High Risk Group
por: Arimappamagan, Arivazhagan, et al.
Publicado: (2013) -
An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals
por: Nijaguna, Mamatha B., et al.
Publicado: (2015) -
Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2
por: Suvasini, Ramaswamy, et al.
Publicado: (2011) -
Impact of somatic copy number alterations on the glioblastoma miRNome: miR‐4484 is a genomically deleted tumour suppressor
por: Nawaz, Zahid, et al.
Publicado: (2017)